Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully carried out a first-in-human clinical evaluation of a robot-assisted peripheral artery intervention of an iliac artery in the department of vascular surgery at Changhai Hospital in Shanghai, China.
The procedure was performed by Qing-Sheng Lu, MD, and colleagues. The endovascular intervention surgical robot, combined with digital subtraction angiography (DSA), precisely evaluated the target lesion and location, and completed a refined operation process to better ensure the safety of the procedure, reduce iatrogenic injury, and reduce the incidence of complications and postoperative reintervention rate, a press release from Aopeng Medical reports.
According to Aopeng Medical, the Allvas endovascular intervention surgical robot is the first platform-robot in peripheral artery intervention with independent intellectual property rights in China. Its core technology covers robot architecture design, robotic arm and actuator process design, force feedback mechanism, software algorithm and automated surgery, and system integration. Aopeng Medical claims that the Allvas is the world’s first universal peripheral artery interventional robot. Early this year, the company completed what it asserts to be world’s first in-human clinical trial of robot-assisted endovascular aortic repair of thoracic aortic aneurysm and abdominal aortic aneurysm.
The traditional surgical treatment has numerous side effects, such as high trauma, high risk, difficulty and multiple complications. In comparison, Aopeng Medical alleges that its endovascular intervention surgical robot, Allvas, can achieve precise positioning through digital technology, which meets specific needs from the individual patient. The company adds that Allvas is also expected to reduce the radiation dose received by the operator by more than 90% and improve the precision of surgical manipulation, thus helping physicians to achieve higher efficiency and more satisfactory effects in clinical practice.